Outsized Demand in Canada’s Cannabis Market Triggers

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
387
Outsized Demand in Canada’s Cannabis Market Triggers Upswing in Smart Money Flowing North

NetworkNewsWire Coverage: For 17 years Canada has provided legal access to medical cannabis to its citizens, and now the country is expected to legalize recreational marijuana by July 2018. With sales of Canadian medical cannabis projected to exceed $8 billion by 2024 (http://nnw.fm/bEi4r) and the recreational market estimated to be worth over $18 billion annually (http://nnw.fm/x49Ay), investment capital has been pouring into Canada’s licensed producers (LPs). Though the demand for cannabis is projected to exceed 600,000 kilograms a year (about 1.3 million pounds), Canada’s LPs currently only cultivate about 20,000 pounds of dried marijuana annually. This immense impending imbalance is a magnet for serious capital investment. It also presents enormous domestic opportunities for one of Canada’s premier producers, ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) (ABCCF Profile), which produces only organically grown, pesticide-free, standardized product and produces among the highest yields within the Canadian sector. Other publicly traded cannabis companies vying for position include Cronos Group Inc. (TSX-V: MJN) (OTC: PRMCF), Maricann Group Inc. (CSE: MARI) (OTCQB: MRRCF), Emblem Corp., (TSX.V: EMC) (OTC: EMMBF), with cannabis finance company, Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTCQB: CBWTF), looking to profit by injecting capital into select growers.

Canada’s initial objective in recreational legalization is to eliminate criminal elements that made a fortune trafficking in marijuana. By getting marijuana out of the black market and into a regulated environment, Canada will generate significant tax revenues and enable it become the first developed country in the world to legalize recreational use. Managing the complexities of integrating the programs will be a delicate balance, but despite the challenges, suppliers are optimistic that legal recreational sales will be a reality by summer. Once fully implemented, Canada could be in the enviable position of being the only regulated producer of marijuana products in the world. In the interim, money keeps streaming into licensed suppliers; $685 million in investment capital was infused into publically traded licensed producers last year and this year looks to be even bigger. In November, Constellation Brands, a major beer and wine distributor in the United States, pumped $245 million into Canadian licensed medical marijuana growers (http://nnw.fm/Dl3Ew).

To become a licensed producer is a marathon exercise in bureaucracy that can take up to three years, with only 3% of applications ultimately approved. Health Canada conducts thorough reviews of applications, ensures compliance, conducts frequent inspections, and enforces stringent standards. A pioneer in Canadian medical cannabis, ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), has been licensed in good standing since 2014 with no history of product recalls, and proprietary computer-controlled production systems that have bolstered the company’s reputation for its consistent pharmaceutical-grade cannabis. Recognizing early on that if the plant was to be effectively utilized as medicine, production had to be standardized from batch to batch, year-over-year, ABcann took an unprecedented scientific approach to medical cannabis production and established a $1.5 million research contract with the University of Guelph, a world leader in controlled environmental growth systems. The scientific collaboration led to ABcann’s proprietary cultivation methods that produce the highest consistent quality cannabis with yields that double the industry standards. Precise computer control of every possible variable allows ABcann to reliably homogenize the environmental experience so each plant reacts and produces the exact same medical compounds each and every grow cycle. The success of company’s proprietary technique is reflected in its 94.7 percent customer retention rate, 30 percent month-over-month customer growth and its current yield rate which is nearly double the industry average (http://nnw.fm/w1vUW). ABcann’s scientific approach to medicine has established the company as an industry leader for quality and consistency and a reputation for pharmaceutical-grade products, a crucial factor to capitalize on international market opportunities. The company’s modular approach to systems technology mitigates start up risks while ensuring consistency and product quality anywhere in the world. ABcann is already tactically targeting Western Europe.

ABcann’s success didn’t go unnoticed. The company went public in May 2017, raising nearly $12 million in a private placement and another $25 million in debentures. Shortly after, PI Financial pegged a one-year share price target of $2.25 (USD). ABcann recently announced the receipt of $11.9 million in proceeds from the exercise of warrants, and with a significant investment from Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTCQB: CBWTF), brings ABcann’s current cash position to about $45 million today. Priced significantly above market, ABcann announced on in August (http://nnw.fm/aVAL7) the close of an initial $15 million investment by Cannabis Wheaton, which has raised over $85 million in the last six months, funds licensed or nearly licensed cannabis producers with smart money, brings in experts to evaluate budgets, and injects capital at important development phases.

Once facilities are producing, Cannabis Wheaton gets a royalty on the sale of one-third of the output, which it negotiates to purchase at direct cost. Chuck Rifici, Cannabis Wheaton’s CEO, commented on the investment, “This now adds a sixth license to the Cannabis Wheaton portfolio, and our first publicly traded producer with a sales license. Over the past three years, I’ve watched ABcann’s involvement and evolution in the Canadian cannabis industry. They are widely recognized for their proprietary cultivation methods that produce high quality cannabis with industry leading yields.”

This initial investment is only part of a larger $30 million phased investment for construction of an additional 50,000 square feet of pure cultivation space next to ABcann’s current 14,000-square-foot cannabis cultivation facility in Ontario, Canada. ABcann’s second production facility, its 65-acre Kimmett property, has construction plans for a 100,000-square-foot purpose-built facility taking production capacity to 20,000 kilograms per year and positioning ABcann for hyperbolic expansion in the Canadian cannabis industry.

Others vying for market position include Maricann Group (CSE: MARI) (OTCQB: MRRCF), which is expanding its cultivation, extraction and production facilities, has raised in excess of $60 million over the last year, some of which was at a $250 million pre-money valuation. However, the company reported that Q2 sales declined by 27% from previous year levels and down 42% compared to Q1. Underscoring the importance of environmental controls, Maricann attributed the shortfall to a March windstorm that allowed sand to enter its greenhouses and ultimately caused destruction of all impacted plants. Since going public less than a year ago, Emblem (TSX.V: EMC) (OTC: EMMBF) has attracted nearly $27 million in fresh capital and has the same size growing facility as ABcann’s current facility. Cronos Group (TSX-V: MJN) (OTC: PRMCF), which operates two wholly-owned licensed producers collectively situated on more than 125 acres of agricultural, licensed land, has garnered over $80 million in debt and equity financing in just the last three months.

Smart money continues to pour into Canadian LPs at an unprecedented rate, and appears to be on the upswing. Obvious initial indications would be for the forthcoming legalization of recreational use. There’s certain to be a bonanza of opportunity upon implementation, but smart money capitalizes on not only the impending obvious but also on strategic longer-term considerations. Select Canadian medical cannabis companies will be uniquely positioned to capitalize on gigantic global growth opportunities. Investors seeking substantial capital appreciation should strongly consider following the smart money.

For more information on ABcann Global please visit: ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

VIVO Cannabis Inc. (VVCIF) Stock Research Links

VVCIF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 343

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 34

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 306

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Guangdong-US Trade: LED Screens, Beef & Trust Make Waves

Updated Category News Views 0

Guangdong's Economic Ballet with the U.S. Grab a cup of coffee, and let's unravel how Guangdong and the U.S. are tangoing their way through trade like nobody's business! Guangdong, the heavyweight champ for U.S.-China trade transactions, notched up a cool 685.27 billion yuan ($102 billion) in the first eight months of 2026. That's a healthy jump of 6.9% year on year, mind...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 635

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 110

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 119

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 184

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading

Top 5 Most Recently Viewed Articles

Cordance Medical Secures $8M Seed Funding for Brain Solutions

Updated Category News Views 235

Groundbreaking Seed Financing for Cordance Medical Cordance Medical, a leader in noninvasive focused ultrasound technology for treating brain diseases, has successfully completed an oversubscribed seed financing round. This milestone was highlighted by exceeding the initial $8 million target, with participation from both new and existing investors such as Shanda Grab...

Continue Reading
Man Group PLC Discloses Open Positions for Aviva PLC

Updated Category News Views 179

Man Group PLC Reports on Relevant Securities In a significant disclosure, Man Group PLC has announced its public opening position in relation to Aviva PLC, emphasizing transparency in its dealings concerning relevant securities. The regulations governing such disclosures necessitate comprehensive reporting, particularly when interests exceed 1% of the relevant securities....

Continue Reading
Baird Raises Griffon Corp Price Target to $92, Outperform Rating

Updated Category News Views 63

Baird Updates Griffon Corp's Stock Projection Baird has elevated its price target on shares of Griffon Corp (NYSE: GFF) from $84.00 to $92.00. This revision to the target price comes with a maintained Outperform rating, signaling strong confidence in the company's outlook. The analyst from Baird forecasts a gradual increase in Griffon's fiscal fourth-quarter financial...

Continue Reading
Experience SoCal Car Culture at SPARQ's LA Auto Show Exhibit

Updated Category News Views 316

SPARQ Returns to LA Auto Show with Exciting Exhibit California's automotive AI startup SPARQ is making waves by returning to the highly anticipated Los Angeles Auto Show this November. This year, visitors can expect an immersive experience inside the Concourse Hall, showcasing an impressive lineup of hypercars, Formula 1 vehicles, and famous cars from iconic films such as...

Continue Reading
Sagent Behavioral Health: A New Era for Mental Wellness Providers

Updated Category News Views 616

Sagent Behavioral Health: Transforming Behavioral Healthcare Sagent Behavioral Health marks a significant advancement in the provision of mental health services in the Midwest. With the consolidation of Nystrom & Associates and its affiliated brands, including Ellie Mental Health, LifeWorks, and several others, this new entity aims to create a unified and robust network...

Continue Reading